Research programme: neurological disorders therapeutics - Pfizer/UCI

Drug Profile

Research programme: neurological disorders therapeutics - Pfizer/UCI

Alternative Names: G protein-coupled receptor modulators - Pfizer; GPCR modulators - Pfizer

Latest Information Update: 13 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer; University of California at Irvine
  • Class
  • Mechanism of Action G protein-coupled receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Neurological disorders

Most Recent Events

  • 11 Dec 2002 NeoTherapeutics is now called Spectrum Pharmaceuticals
  • 18 Apr 2001 Preclinical development for Neurological disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top